Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ARRIVENT BIOPHARMA, INC. (AVBP) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ARRIVENT BIOPHARMA, INC. (AVBP), most recent 12 months reported: net loss $163.74M. Latest balance sheet on file: liquid cash $373.12M. From SEC filings. Others in Pharmaceutical Preparations: APIMEDS PHARMACEUTICALS US, INC. · Aptevo Therapeutics Inc. · ARTELO BIOSCIENCES, INC. · ATOSSA THERAPEUTICS, INC. · Atea Pharmaceuticals, Inc. · Azitra, Inc. · BridgeBio Oncology Therapeutics, Inc. · Bicara Therapeutics Inc.

Stock screener

Watchlist